[
  {
    "title": "透视龙虎榜：数字经济成为主流热点 众生药业遭机构抢跑！",
    "href": "http://stock.jrj.com.cn/2023/01/03210337256655.shtml",
    "datetime": "2023-01-03 21:03:04",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业1月3日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2023/01/03180037255916.shtml",
    "datetime": "2023-01-03 18:00:22",
    "code": "002317"
  },
  {
    "title": "众生药业今日涨停 四机构净卖出2亿元",
    "href": "http://stock.jrj.com.cn/2023/01/03163437255445.shtml",
    "datetime": "2023-01-03 16:34:21",
    "code": "002317"
  },
  {
    "title": "A股异动 | 众生药业涨6% 治疗轻型和普通型新冠病毒感染患者创新药RAY1216片Ⅲ期临床试验全部患者入组",
    "href": "http://stock.jrj.com.cn/2023/01/03093437254086.shtml",
    "datetime": "2023-01-03 09:34:49",
    "code": "002317"
  },
  {
    "title": "最新龙虎榜：机构买入众生药业超5000万，知名游资买入徐家汇",
    "href": "http://stock.jrj.com.cn/hotstock/2023/01/03072137253755.shtml",
    "datetime": "2023-01-03 07:21:03",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：RAY1216片完成III期临床试验全部患者入组",
    "href": "http://stock.jrj.com.cn/2023/01/02182337253287.shtml",
    "datetime": "2023-01-02 18:23:41",
    "code": "002317"
  },
  {
    "title": "众生药业：创新药RAY1216片用于治疗轻型和普通型新冠病毒感染患者完成Ⅲ期临床试验全部患者入组",
    "href": "http://stock.jrj.com.cn/2023/01/02163837253157.shtml",
    "datetime": "2023-01-02 16:38:52",
    "code": "002317"
  },
  {
    "title": "众生药业：创新药RAY1216片用于治疗轻型和普通型新冠病毒感染患者完成Ⅲ期临床试验全部患者入组",
    "href": "http://stock.jrj.com.cn/2023/01/02162837253146.shtml",
    "datetime": "2023-01-02 16:28:45",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：众生睿创拟以现金增资方式引入投资者",
    "href": "http://stock.jrj.com.cn/2022/12/30221337251347.shtml",
    "datetime": "2022-12-30 22:13:57",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业12月30日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/30180037250310.shtml",
    "datetime": "2022-12-30 18:00:13",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：一类创新药RAY1225注射液临床试验注册申请获受理",
    "href": "http://stock.jrj.com.cn/2022/12/29174637246912.shtml",
    "datetime": "2022-12-29 17:46:42",
    "code": "002317"
  },
  {
    "title": "最新龙虎榜：机构买入凯美特气超9000万，知名游资买入众生药业",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/28075737241905.shtml",
    "datetime": "2022-12-28 07:57:11",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：聘请龙超峰担任公司研发顾问",
    "href": "http://stock.jrj.com.cn/2022/12/27201937241495.shtml",
    "datetime": "2022-12-27 20:19:05",
    "code": "002317"
  },
  {
    "title": "龙虎榜解读：4机构合计净买入9104万元凯美特气，方新侠3亿元死磕众生药业被埋",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/27185237241281.shtml",
    "datetime": "2022-12-27 18:52:01",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业12月27日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/27180037241067.shtml",
    "datetime": "2022-12-27 18:00:23",
    "code": "002317"
  },
  {
    "title": "主力揭秘：主力增持证券、白酒，大幅减持医药生物，众生药业主力资金净流出超6亿元",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/27152337240373.shtml",
    "datetime": "2022-12-27 15:23:16",
    "code": "002317"
  },
  {
    "title": "主力揭秘：主力增持证券、白酒，大幅减持医药生物，众生药业主力资金净流出6.5亿元",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/27151737240363.shtml",
    "datetime": "2022-12-27 15:17:04",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业12月26日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/26180037238592.shtml",
    "datetime": "2022-12-26 18:00:22",
    "code": "002317"
  },
  {
    "title": "最新龙虎榜：机构买入水井坊超2亿，知名游资买入众生药业",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/23074837233012.shtml",
    "datetime": "2022-12-23 07:48:06",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业12月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/22180037231982.shtml",
    "datetime": "2022-12-22 18:00:22",
    "code": "002317"
  },
  {
    "title": "众生药业：公司创新药临床试验进度等具有一定不确定性",
    "href": "http://stock.jrj.com.cn/2022/12/22173737231829.shtml",
    "datetime": "2022-12-22 17:37:30",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：用于治疗成人单纯性甲型流感的一类创新药物ZSP1273片正处于III期临床试验阶段",
    "href": "http://stock.jrj.com.cn/2022/12/22171837231760.shtml",
    "datetime": "2022-12-22 17:18:15",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业12月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/21180037228953.shtml",
    "datetime": "2022-12-21 18:00:52",
    "code": "002317"
  },
  {
    "title": "龙虎榜解读：12月底有大消息？众生药业再现“机构对轰”，多家游资抱团数据要素，小鳄鱼1.49亿元封板人民网",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/21175537228925.shtml",
    "datetime": "2022-12-21 17:55:04",
    "code": "002317"
  },
  {
    "title": "众生药业今日涨停 机构资金现分歧",
    "href": "http://stock.jrj.com.cn/2022/12/21163237228464.shtml",
    "datetime": "2022-12-21 16:32:14",
    "code": "002317"
  },
  {
    "title": "主力揭秘：主力资金出逃三大热门板块，众生药业获主力逆势增持6.78亿元",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/21151537228229.shtml",
    "datetime": "2022-12-21 15:15:40",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业12月19日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/19180037223086.shtml",
    "datetime": "2022-12-19 18:00:12",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：控股子公司获得发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/12/19173437222948.shtml",
    "datetime": "2022-12-19 17:34:04",
    "code": "002317"
  },
  {
    "title": "龙虎榜 | 众生药业单日净买入额最多，机构净卖出国联股份2.25亿元",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/16183837218951.shtml",
    "datetime": "2022-12-16 18:38:11",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业12月16日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/16180037218753.shtml",
    "datetime": "2022-12-16 18:00:55",
    "code": "002317"
  },
  {
    "title": "主力揭秘：主力加仓半导体，减持医药白酒，众生药业、中国医药获主力资金逆势买入",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/15151137214934.shtml",
    "datetime": "2022-12-15 15:11:14",
    "code": "002317"
  },
  {
    "title": "众生药业：退出医药健康产业并购基金",
    "href": "http://stock.jrj.com.cn/2022/12/11202937204066.shtml",
    "datetime": "2022-12-11 20:29:36",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：退出医药健康产业并购基金",
    "href": "http://stock.jrj.com.cn/2022/12/11173437203951.shtml",
    "datetime": "2022-12-11 17:34:51",
    "code": "002317"
  },
  {
    "title": "龙虎榜：多家顶级游资联手打榜中油资本，方新侠3天卖出众生药业6个“小目标”",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/05194337189845.shtml",
    "datetime": "2022-12-05 19:43:27",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业12月5日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/05180037189397.shtml",
    "datetime": "2022-12-05 18:00:53",
    "code": "002317"
  },
  {
    "title": "一周主力资金：酿酒行业净流入超50亿元，众生药业、以岭药业净流出金额达18亿元",
    "href": "http://stock.jrj.com.cn/ipo/2022/12/04093037186747.shtml",
    "datetime": "2022-12-04 09:30:59",
    "code": "002317"
  },
  {
    "title": "龙虎榜：游资联手惨遭机构“爆头“，2家机构卖出2.1亿众生药业，留给散户一地鸡毛",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/01183537182251.shtml",
    "datetime": "2022-12-01 18:35:31",
    "code": "002317"
  },
  {
    "title": "12月券商金股出炉，中国人寿最被看好，众生药业成11月“金股王”",
    "href": "http://stock.jrj.com.cn/2022/12/01182637182205.shtml",
    "datetime": "2022-12-01 18:26:51",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业12月1日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/01180037182083.shtml",
    "datetime": "2022-12-01 18:00:25",
    "code": "002317"
  },
  {
    "title": "众生药业今日跌停 两机构合计卖出2.1亿元",
    "href": "http://stock.jrj.com.cn/2022/12/01163537181590.shtml",
    "datetime": "2022-12-01 16:35:55",
    "code": "002317"
  },
  {
    "title": "众生药业今日跌停 两机构合计卖出2.1亿元",
    "href": "http://stock.jrj.com.cn/2022/12/01162737181545.shtml",
    "datetime": "2022-12-01 16:27:53",
    "code": "002317"
  },
  {
    "title": "新冠药概念股开盘跳水，众生药业、特一药业双双跌停",
    "href": "http://stock.jrj.com.cn/2022/12/01093737180362.shtml",
    "datetime": "2022-12-01 09:37:04",
    "code": "002317"
  },
  {
    "title": "三大指数震荡整理，资金抢筹众生药业",
    "href": "http://stock.jrj.com.cn/invest/2022/11/18071937148511.shtml",
    "datetime": "2022-11-18 07:19:10",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业11月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/17180037147293.shtml",
    "datetime": "2022-11-17 18:00:14",
    "code": "002317"
  },
  {
    "title": "龙虎榜：一机构高位进场买入1.3亿以岭药业，北上资金午后进场抢筹完美世界、三七互娱",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/17174237147177.shtml",
    "datetime": "2022-11-17 17:42:08",
    "code": "002317"
  },
  {
    "title": "主力资金：主力扫货医药板块，众生药业净流入超11亿，以岭药业涨停创历史新高",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/17152937146551.shtml",
    "datetime": "2022-11-17 15:29:05",
    "code": "002317"
  },
  {
    "title": "中药板块走高，康缘药业、金花股份、众生药业涨停",
    "href": "http://stock.jrj.com.cn/2022/11/17100437145783.shtml",
    "datetime": "2022-11-17 10:04:08",
    "code": "002317"
  },
  {
    "title": "众生药业今日跌9.48% 一机构净买入1亿元",
    "href": "http://stock.jrj.com.cn/2022/11/16162637143707.shtml",
    "datetime": "2022-11-16 16:26:39",
    "code": "002317"
  },
  {
    "title": "主力资金：以岭药业被主力净卖出14亿元，北上资金连续4天合计净买入400亿元",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/16151237143441.shtml",
    "datetime": "2022-11-16 15:12:38",
    "code": "002317"
  },
  {
    "title": "A股异动丨众生药业再度逼近涨停 新冠药Ⅲ期临床研究完成首例受试者入",
    "href": "http://stock.jrj.com.cn/2022/11/15134237139916.shtml",
    "datetime": "2022-11-15 13:42:17",
    "code": "002317"
  },
  {
    "title": "最新龙虎榜：机构买入众生药业超2亿，知名游资买入福石控股",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/15072537138865.shtml",
    "datetime": "2022-11-15 07:25:15",
    "code": "002317"
  },
  {
    "title": "七天五板众生药业：新冠药RAY1216片Ⅲ期临床研究完成首例受试者入组",
    "href": "http://stock.jrj.com.cn/2022/11/14181037137708.shtml",
    "datetime": "2022-11-14 18:10:05",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业11月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/14180037137652.shtml",
    "datetime": "2022-11-14 18:00:05",
    "code": "002317"
  },
  {
    "title": "龙虎榜：3家机构净卖出5.14亿鱼跃医疗，深股通连续两日抢筹以岭药业，众生药业天地板后再度涨停",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/14174537137546.shtml",
    "datetime": "2022-11-14 17:45:29",
    "code": "002317"
  },
  {
    "title": "龙虎榜：最强妖王被机构砸出“天地板”，顶级游资被埋，股民哀叹：股崩的时候，没有一毛钱是干净的！",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/11194237132503.shtml",
    "datetime": "2022-11-11 19:42:45",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业11月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/11180037132049.shtml",
    "datetime": "2022-11-11 18:00:06",
    "code": "002317"
  },
  {
    "title": "沸腾！大涨原因不用找了！医药股却突发闪崩！谁干的？股民：刚从歌尔出来，就追了众生药业....",
    "href": "http://stock.jrj.com.cn/2022/11/11164837131597.shtml",
    "datetime": "2022-11-11 16:48:15",
    "code": "002317"
  },
  {
    "title": "收评：两市成交额重回万亿，房地产、贵金属板块爆发，众生药业、榕基软件上演“天地板”",
    "href": "http://stock.jrj.com.cn/2022/11/11150937131055.shtml",
    "datetime": "2022-11-11 15:09:06",
    "code": "002317"
  },
  {
    "title": "众生药业天地板，以岭药业跌停",
    "href": "http://stock.jrj.com.cn/2022/11/11143637130947.shtml",
    "datetime": "2022-11-11 14:36:27",
    "code": "002317"
  },
  {
    "title": "新冠药板块跳水，康希诺翻绿，众生药业炸板",
    "href": "http://stock.jrj.com.cn/2022/11/11141837130894.shtml",
    "datetime": "2022-11-11 14:18:25",
    "code": "002317"
  },
  {
    "title": "新冠药概念持续走强，众生药业涨停",
    "href": "http://stock.jrj.com.cn/2022/11/11094837130050.shtml",
    "datetime": "2022-11-11 09:48:40",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业11月10日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/10180037128249.shtml",
    "datetime": "2022-11-10 18:00:17",
    "code": "002317"
  },
  {
    "title": "龙虎榜：4家卖出2.2亿元联泓新科，多家游资锁仓众生药业",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/10174137128100.shtml",
    "datetime": "2022-11-10 17:41:47",
    "code": "002317"
  },
  {
    "title": "A股异动丨众生药业再涨6.74% 子公司利福平胶囊通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/11/10103037126685.shtml",
    "datetime": "2022-11-10 10:30:38",
    "code": "002317"
  },
  {
    "title": "新冠药概念走势活跃 众生药业股价创历史新高",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/10084137126294.shtml",
    "datetime": "2022-11-10 08:41:06",
    "code": "002317"
  },
  {
    "title": "龙虎榜：机构卖卖卖，游资买买买，众生药业何去何从？",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/09181237124793.shtml",
    "datetime": "2022-11-09 18:12:32",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：子公司利福平胶囊通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/11/09181237124825.shtml",
    "datetime": "2022-11-09 18:12:28",
    "code": "002317"
  },
  {
    "title": "众生药业涨停 三机构合计卖出2.83亿元",
    "href": "http://stock.jrj.com.cn/2022/11/09171437124421.shtml",
    "datetime": "2022-11-09 17:14:46",
    "code": "002317"
  },
  {
    "title": "众生药业涨停 三机构合计卖出2.83亿元",
    "href": "http://stock.jrj.com.cn/2022/11/09171237124412.shtml",
    "datetime": "2022-11-09 17:12:56",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)累涨170%，公司提示风险",
    "href": "http://stock.jrj.com.cn/2022/11/09142337123743.shtml",
    "datetime": "2022-11-09 14:23:37",
    "code": "002317"
  },
  {
    "title": "A股异动丨众生药业再创新高 即便澄清称口服抗新型冠状病毒药物存在不确定性",
    "href": "http://stock.jrj.com.cn/2022/11/09141837123710.shtml",
    "datetime": "2022-11-09 14:18:13",
    "code": "002317"
  },
  {
    "title": "中药概念板块走强，特一药业、众生药业双双涨停",
    "href": "http://stock.jrj.com.cn/2022/11/09100037122978.shtml",
    "datetime": "2022-11-09 10:00:41",
    "code": "002317"
  },
  {
    "title": "透视龙虎榜：众生药业兑现离场？西安饮食出现分歧尾盘烂板",
    "href": "http://stock.jrj.com.cn/2022/11/08221437122083.shtml",
    "datetime": "2022-11-08 22:14:40",
    "code": "002317"
  },
  {
    "title": "众生药业：公司口服抗新型冠状病毒药物存在不确定性",
    "href": "http://stock.jrj.com.cn/2022/11/08182337121272.shtml",
    "datetime": "2022-11-08 18:23:47",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业11月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/08180037121157.shtml",
    "datetime": "2022-11-08 18:00:10",
    "code": "002317"
  },
  {
    "title": "龙虎榜：机构“清仓”众生药业，中药板块会团灭么？",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/08174737121067.shtml",
    "datetime": "2022-11-08 17:47:22",
    "code": "002317"
  },
  {
    "title": "A股异动 | 众生药业续创新高 口服新冠药启动Ⅲ期临床",
    "href": "http://stock.jrj.com.cn/2022/11/08095237119397.shtml",
    "datetime": "2022-11-08 09:52:08",
    "code": "002317"
  },
  {
    "title": "A股异动 | 众生药业涨6% 新冠创新药RAY1216片获得Ⅲ期临床试验组长单位伦理批件",
    "href": "http://stock.jrj.com.cn/2022/11/04095337111853.shtml",
    "datetime": "2022-11-04 09:53:29",
    "code": "002317"
  },
  {
    "title": "众生药业：新冠创新药物RAY1216片获得Ⅲ期临床试验组长单位伦理批件",
    "href": "http://stock.jrj.com.cn/2022/11/03201637110926.shtml",
    "datetime": "2022-11-03 20:16:34",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：众生睿创一类创新药RAY1216片获Ⅲ期临床试验组长单位伦理批件",
    "href": "http://stock.jrj.com.cn/2022/11/03200737110913.shtml",
    "datetime": "2022-11-03 20:07:47",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业11月1日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/01180037103934.shtml",
    "datetime": "2022-11-01 18:00:41",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：第三季度净利4649.62万元，同比增长79.08%",
    "href": "http://stock.jrj.com.cn/2022/10/28210737095629.shtml",
    "datetime": "2022-10-28 21:07:41",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：子公司溴芬酸钠原料药上市申请获批",
    "href": "http://stock.jrj.com.cn/2022/10/26221637087622.shtml",
    "datetime": "2022-10-26 22:16:31",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：口服抗新型冠状病毒3CL蛋白酶抑制剂RAY1216片目前处于II/III期临床研究关键准备阶段",
    "href": "http://stock.jrj.com.cn/2022/10/23210637076270.shtml",
    "datetime": "2022-10-23 21:06:37",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业10月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/10/21180037073977.shtml",
    "datetime": "2022-10-21 18:00:24",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：实控人张玉冲质押的合计2596万股延期购回",
    "href": "http://stock.jrj.com.cn/2022/10/14181637056816.shtml",
    "datetime": "2022-10-14 18:16:54",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：定增申请获中国证监会受理",
    "href": "http://stock.jrj.com.cn/2022/10/12174637050499.shtml",
    "datetime": "2022-10-12 17:46:34",
    "code": "002317"
  },
  {
    "title": "最新龙虎榜：机构买入众生药业超6000万，知名游资买入海光信息",
    "href": "http://stock.jrj.com.cn/hotstock/2022/10/12074037048698.shtml",
    "datetime": "2022-10-12 07:40:50",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业10月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/10/11180037047649.shtml",
    "datetime": "2022-10-11 18:00:29",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)获得1项美国专利证书",
    "href": "http://stock.jrj.com.cn/2022/10/10174237044430.shtml",
    "datetime": "2022-10-10 17:42:56",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)控股子公司获得2项国际专利证书",
    "href": "http://stock.jrj.com.cn/2022/09/01172636963431.shtml",
    "datetime": "2022-09-01 17:26:52",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：注射用帕瑞昔布钠获批上市",
    "href": "http://stock.jrj.com.cn/2022/08/22181936922341.shtml",
    "datetime": "2022-08-22 18:19:15",
    "code": "002317"
  },
  {
    "title": "A股异动丨众生药业(002317.SZ)跌4.48% 半年度净利润2.02亿元 同比下降29.73%",
    "href": "http://stock.jrj.com.cn/2022/08/09095836881737.shtml",
    "datetime": "2022-08-09 09:58:15",
    "code": "002317"
  },
  {
    "title": "众生药业披露2022年半年报 实现营收13.26亿元",
    "href": "http://stock.jrj.com.cn/2022/08/09092536881586.shtml",
    "datetime": "2022-08-09 09:25:00",
    "code": "002317"
  },
  {
    "title": "众生药业2022年上半年净利2.02亿同比下滑29.73% 票据贴现利息支出增加",
    "href": "http://stock.jrj.com.cn/2022/08/08223136880680.shtml",
    "datetime": "2022-08-08 22:31:18",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)半年度净利润2.02亿元、同比下降29.73%",
    "href": "http://stock.jrj.com.cn/2022/08/08200536880256.shtml",
    "datetime": "2022-08-08 20:05:03",
    "code": "002317"
  },
  {
    "title": "A股异动 | 利好叠加 众生药业涨近5%",
    "href": "http://stock.jrj.com.cn/2022/08/05101736872856.shtml",
    "datetime": "2022-08-05 10:17:13",
    "code": "002317"
  },
  {
    "title": "众生药业：新冠药RAY1216片Ⅰ期临床试验完成全部受试者临床观察",
    "href": "http://stock.jrj.com.cn/2022/08/04174936870831.shtml",
    "datetime": "2022-08-04 17:49:46",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：RAY1216片Ⅰ期临床研究完成全部受试者临床观察",
    "href": "http://stock.jrj.com.cn/2022/08/04173936870733.shtml",
    "datetime": "2022-08-04 17:39:49",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：近日获得1项日本专利证书",
    "href": "http://stock.jrj.com.cn/2022/08/03181536867502.shtml",
    "datetime": "2022-08-03 18:15:43",
    "code": "002317"
  },
  {
    "title": "众生药业控股股东张玉立质押1237万股 用于偿还债务",
    "href": "http://stock.jrj.com.cn/2022/07/20223136830084.shtml",
    "datetime": "2022-07-20 22:31:00",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：张玉立质押1237万股",
    "href": "http://stock.jrj.com.cn/2022/07/20213936829980.shtml",
    "datetime": "2022-07-20 21:39:00",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)获得1项日本专利证书",
    "href": "http://stock.jrj.com.cn/2022/07/13183536808229.shtml",
    "datetime": "2022-07-13 18:35:36",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业7月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/07/11180036799573.shtml",
    "datetime": "2022-07-11 18:00:14",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业7月11日成交明细(dev)",
    "href": "http://stock.jrj.com.cn/2022/07/11180036799557.shtml",
    "datetime": "2022-07-11 18:00:01",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)拟定增募资不超6.788亿元、用于抗肿瘤药研发项目等等",
    "href": "http://stock.jrj.com.cn/2022/07/05220836785062.shtml",
    "datetime": "2022-07-05 22:08:37",
    "code": "002317"
  },
  {
    "title": "A股异动 | 众生药业涨6% 口服抗新冠病毒药物RAY1216片Ⅰ期临床试验完成首例受试者入组",
    "href": "http://stock.jrj.com.cn/2022/05/23100236669337.shtml",
    "datetime": "2022-05-23 10:02:59",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：一类创新药RAY1216片Ⅰ期临试完成首例受试者入组",
    "href": "http://stock.jrj.com.cn/2022/05/22170336668469.shtml",
    "datetime": "2022-05-22 17:03:37",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)2021年年度权益分派10派2元 股权登记日5月26日",
    "href": "http://stock.jrj.com.cn/2022/05/20175436666441.shtml",
    "datetime": "2022-05-20 17:54:38",
    "code": "002317"
  },
  {
    "title": "众生药业创新药“再下一城” 传统业务增长缓慢研发投入不占优",
    "href": "http://stock.jrj.com.cn/2022/05/18083036657578.shtml",
    "datetime": "2022-05-18 08:30:00",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)获得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/05/17201336656432.shtml",
    "datetime": "2022-05-17 20:13:54",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业5月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/17180036655783.shtml",
    "datetime": "2022-05-17 18:00:11",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业5月17日成交明细(dev)",
    "href": "http://stock.jrj.com.cn/2022/05/17180036655775.shtml",
    "datetime": "2022-05-17 18:00:04",
    "code": "002317"
  },
  {
    "title": "A股异动丨众生药业(002317.SZ)涨5.53% 新冠药RAY1216片临床试验获国家药监局批准",
    "href": "http://stock.jrj.com.cn/2022/05/16143436650990.shtml",
    "datetime": "2022-05-16 14:34:45",
    "code": "002317"
  },
  {
    "title": "众生药业：子公司一类创新药ZSP1273片Ⅲ期临床试验首例受试者已入组",
    "href": "http://stock.jrj.com.cn/2022/05/16104836650344.shtml",
    "datetime": "2022-05-16 10:48:47",
    "code": "002317"
  },
  {
    "title": "周末上市公司晚间重要公告：众生药业口服抗新冠病毒创新药RAY1216临床试验获批",
    "href": "http://stock.jrj.com.cn/2022/05/15211536649421.shtml",
    "datetime": "2022-05-15 21:15:26",
    "code": "002317"
  },
  {
    "title": "又一款新冠口服药！众生药业3CL蛋白酶抑制剂RAY1216获批临床",
    "href": "http://stock.jrj.com.cn/2022/05/15205536649413.shtml",
    "datetime": "2022-05-15 20:55:10",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：新冠药RAY1216片临床试验获国家药监局批准",
    "href": "http://stock.jrj.com.cn/2022/05/15175836649295.shtml",
    "datetime": "2022-05-15 17:58:25",
    "code": "002317"
  },
  {
    "title": "众生药业口服抗新冠病毒创新药RAY1216临床试验获批",
    "href": "http://stock.jrj.com.cn/2022/05/15172536649255.shtml",
    "datetime": "2022-05-15 17:25:10",
    "code": "002317"
  },
  {
    "title": "众生药业：口服抗新冠病毒创新药RAY1216临床试验获批",
    "href": "http://stock.jrj.com.cn/2022/05/15163936649176.shtml",
    "datetime": "2022-05-15 16:39:48",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业5月12日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/12180036643497.shtml",
    "datetime": "2022-05-12 18:00:16",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业5月12日成交明细(dev)",
    "href": "http://stock.jrj.com.cn/2022/05/12180036643484.shtml",
    "datetime": "2022-05-12 18:00:05",
    "code": "002317"
  },
  {
    "title": "A股异动 | 众生药业涨停 口服抗新冠病毒创新药RAY1216片临床试验注册申请获得受理",
    "href": "http://stock.jrj.com.cn/2022/05/12093836640479.shtml",
    "datetime": "2022-05-12 09:38:41",
    "code": "002317"
  },
  {
    "title": "众生药业口服抗新冠病毒创新药RAY1216片临床试验注册申请获得受理",
    "href": "http://stock.jrj.com.cn/2022/05/11175536634760.shtml",
    "datetime": "2022-05-11 17:55:42",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：子公司一类创新药RAY1216片临床试验注册申请获受理",
    "href": "http://stock.jrj.com.cn/2022/05/11173336634436.shtml",
    "datetime": "2022-05-11 17:33:16",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：控股子公司获得日本专利证书",
    "href": "http://stock.jrj.com.cn/2022/05/09183336608920.shtml",
    "datetime": "2022-05-09 18:33:27",
    "code": "002317"
  },
  {
    "title": "众生药业2022年第一季度净利7459.04万同比增长31.41% 大额存单收益增加",
    "href": "http://stock.jrj.com.cn/2022/05/03191136546534.shtml",
    "datetime": "2022-05-03 19:11:49",
    "code": "002317"
  },
  {
    "title": "众生药业2021年净利2.78亿同比扭亏为盈 董事长陈永红薪酬50.34万",
    "href": "http://stock.jrj.com.cn/2022/04/26171336476372.shtml",
    "datetime": "2022-04-26 17:13:07",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：控股子公司取得高新技术企业证书",
    "href": "http://stock.jrj.com.cn/2022/04/14215236338507.shtml",
    "datetime": "2022-04-14 21:52:10",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：华南药业的羧甲司坦片通过仿制药质量和疗效一致性",
    "href": "http://stock.jrj.com.cn/2022/04/13203336326701.shtml",
    "datetime": "2022-04-13 20:33:33",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：复方丹参片等4项药品拟中选广东联盟中成药集中带量采购",
    "href": "http://stock.jrj.com.cn/2022/04/13195836326465.shtml",
    "datetime": "2022-04-13 19:58:15",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业3月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/25180035123990.shtml",
    "datetime": "2022-03-25 18:00:16",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业3月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/22180034861406.shtml",
    "datetime": "2022-03-22 18:00:44",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：回购账户中的570万股已过户至2022年员工持股计划专户",
    "href": "http://stock.jrj.com.cn/2022/03/18180334846186.shtml",
    "datetime": "2022-03-18 18:03:59",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业3月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/18180034846152.shtml",
    "datetime": "2022-03-18 18:00:52",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业3月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/14180034824818.shtml",
    "datetime": "2022-03-14 18:00:23",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业3月2日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/02180034512907.shtml",
    "datetime": "2022-03-02 18:00:30",
    "code": "002317"
  },
  {
    "title": "众生药业员工持股计划出炉：副董事长张玉冲等9高管认购51%份额 认购价为股价50%",
    "href": "http://stock.jrj.com.cn/2022/03/02105134511183.shtml",
    "datetime": "2022-03-02 10:51:31",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：向77名激励对象授予578万股限制性股票",
    "href": "http://stock.jrj.com.cn/2022/03/01203934509493.shtml",
    "datetime": "2022-03-01 20:39:24",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：控股子公司一类创新药ZSP1273片收到美国FDA药物临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2022/02/28190734500710.shtml",
    "datetime": "2022-02-28 19:07:37",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)拟推2022年员工持股计划",
    "href": "http://stock.jrj.com.cn/2022/02/11210134326603.shtml",
    "datetime": "2022-02-11 21:01:30",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：拟推584万股的2022年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/02/11205734326325.shtml",
    "datetime": "2022-02-11 20:57:24",
    "code": "002317"
  },
  {
    "title": "3天跌超20%，商誉暴雷的众生药业何以为生？",
    "href": "http://stock.jrj.com.cn/2022/01/26084634220241.shtml",
    "datetime": "2022-01-26 08:46:05",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业1月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/24180134205344.shtml",
    "datetime": "2022-01-24 18:01:24",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业1月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/17180034165408.shtml",
    "datetime": "2022-01-17 18:00:34",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业1月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/11180034146832.shtml",
    "datetime": "2022-01-11 18:00:50",
    "code": "002317"
  },
  {
    "title": "众生药业2021年预计净利3.3亿-3.9亿同比扭亏为盈 上年业绩受商誉减值计提影响导致亏损",
    "href": "http://stock.jrj.com.cn/2022/01/05213634126580.shtml",
    "datetime": "2022-01-05 21:36:54",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：2021年度预盈3.3亿元-3.9亿元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2022/01/05201934126247.shtml",
    "datetime": "2022-01-05 20:19:03",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：公司及子公司共有131个产品品规入选医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/05184133965614.shtml",
    "datetime": "2021-12-05 18:41:33",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：控股子公司获得国际专利证书",
    "href": "http://stock.jrj.com.cn/2021/11/30174033944847.shtml",
    "datetime": "2021-11-30 17:40:08",
    "code": "002317"
  },
  {
    "title": "众生药业股价持续攀升至每股12.19元 营收净利双增长同时要警惕长期待摊费用对利润的侵蚀",
    "href": "http://stock.jrj.com.cn/2021/11/26183533924459.shtml",
    "datetime": "2021-11-26 18:35:00",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业11月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/11/25180033919575.shtml",
    "datetime": "2021-11-25 18:00:12",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：控股子公司众生睿创获得日本专利证书",
    "href": "http://stock.jrj.com.cn/2021/11/18193533873899.shtml",
    "datetime": "2021-11-18 19:35:52",
    "code": "002317"
  },
  {
    "title": "众生药业：前三季度扣非净利润2.97亿元 同比增66.50%",
    "href": "http://stock.jrj.com.cn/2021/10/27205833764269.shtml",
    "datetime": "2021-10-27 20:58:54",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：一类创新药ZSP1603已启动用于治疗特发性肺纤维化患者的Ⅰb/Ⅱa期临床试验",
    "href": "http://stock.jrj.com.cn/2021/10/22215433735710.shtml",
    "datetime": "2021-10-22 21:54:04",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：控股子公司获得一项韩国专利证书",
    "href": "http://stock.jrj.com.cn/2021/10/20214433723703.shtml",
    "datetime": "2021-10-20 21:44:14",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：子公司治疗NASH一类创新药ZSP1601片将继续开展IIb期临床试验",
    "href": "http://stock.jrj.com.cn/2021/10/18193933712305.shtml",
    "datetime": "2021-10-18 19:39:28",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：子公司获得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/09/16210633446871.shtml",
    "datetime": "2021-09-16 21:06:11",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：格列吡嗪片通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2021/09/10190233416520.shtml",
    "datetime": "2021-09-10 19:02:16",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：子公司获得1项日本专利证书",
    "href": "http://stock.jrj.com.cn/2021/09/02200133375675.shtml",
    "datetime": "2021-09-02 20:01:55",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)上半年净利升50.16%至2.88亿元",
    "href": "http://stock.jrj.com.cn/2021/08/28013533337365.shtml",
    "datetime": "2021-08-28 01:35:40",
    "code": "002317"
  },
  {
    "title": "众生药业2021年半年度净利2.88亿元 同比净利增加50.16%",
    "href": "http://stock.jrj.com.cn/2021/08/27223133336658.shtml",
    "datetime": "2021-08-27 22:31:55",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：获得1项欧洲专利证书",
    "href": "http://stock.jrj.com.cn/2021/08/12204033244665.shtml",
    "datetime": "2021-08-12 20:40:38",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：完成回购 累计耗资5158.8万元回购592.71万股",
    "href": "http://stock.jrj.com.cn/2021/08/09213233227406.shtml",
    "datetime": "2021-08-09 21:32:00",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)截至7月底已累计回购0.63%的股份",
    "href": "http://stock.jrj.com.cn/2021/08/02211733190801.shtml",
    "datetime": "2021-08-02 21:17:23",
    "code": "002317"
  },
  {
    "title": "众生药业2021年上半年预计净利2.8亿-3亿增长46%-57% 经营业绩较上期上升",
    "href": "http://stock.jrj.com.cn/2021/07/13225633091387.shtml",
    "datetime": "2021-07-13 22:56:57",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)半年度净利润预增46.09%至56.53%",
    "href": "http://stock.jrj.com.cn/2021/07/13202733090857.shtml",
    "datetime": "2021-07-13 20:27:20",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：头孢克肟分散片通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2021/07/08190833065478.shtml",
    "datetime": "2021-07-08 19:08:17",
    "code": "002317"
  },
  {
    "title": "众生药业拟售爱尔眼科股票或兑现4亿 入股一年获3.3倍收益加快资金周转",
    "href": "http://stock.jrj.com.cn/2021/07/06073833050675.shtml",
    "datetime": "2021-07-06 07:38:55",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)截至6月底已累计回购0.59%的股份",
    "href": "http://stock.jrj.com.cn/2021/07/02200533035058.shtml",
    "datetime": "2021-07-02 20:05:04",
    "code": "002317"
  },
  {
    "title": "众生药业：公司正在针对目标靶点开展研发工作 目前还处于早期研发阶段",
    "href": "http://stock.jrj.com.cn/2021/06/21214432971814.shtml",
    "datetime": "2021-06-21 21:44:42",
    "code": "002317"
  },
  {
    "title": "众生药业：公司ZSP1273项目的Ⅲ期临床研究计划入组744例",
    "href": "http://stock.jrj.com.cn/2021/06/21214232971799.shtml",
    "datetime": "2021-06-21 21:42:28",
    "code": "002317"
  },
  {
    "title": "众生药业：公司研发的注射用紫杉醇聚合物胶束处于临床Ⅰ期临床试验阶段 目前已完成首例入组",
    "href": "http://stock.jrj.com.cn/2021/06/18130732953826.shtml",
    "datetime": "2021-06-18 13:07:45",
    "code": "002317"
  },
  {
    "title": "众生药业新药获美国专利证书 研发投入增长20% 布局抗流感新药",
    "href": "http://stock.jrj.com.cn/2021/06/17082432945802.shtml",
    "datetime": "2021-06-17 08:24:00",
    "code": "002317"
  },
  {
    "title": "众生药业：公司发掘核心产品在预防和康复阶段的临床价值 激活休眠品种市场价值",
    "href": "http://stock.jrj.com.cn/2021/06/08142332893059.shtml",
    "datetime": "2021-06-08 14:23:53",
    "code": "002317"
  },
  {
    "title": "众生药业：公司共承担了4个国家级重大新药创制项目、3个省级重点研发领域项目",
    "href": "http://stock.jrj.com.cn/2021/06/08141632893044.shtml",
    "datetime": "2021-06-08 14:16:33",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：收到韩国知识产权局颁发的专利证书",
    "href": "http://stock.jrj.com.cn/2021/06/04201332875614.shtml",
    "datetime": "2021-06-04 20:13:35",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)截至5月底已累计回购266.8647万股",
    "href": "http://stock.jrj.com.cn/2021/06/01212032859431.shtml",
    "datetime": "2021-06-01 21:20:58",
    "code": "002317"
  },
  {
    "title": "众生药业：先强药业研发的NMN（β-烟酰胺单核苷酸）已完成中试",
    "href": "http://stock.jrj.com.cn/2021/05/26091732821152.shtml",
    "datetime": "2021-05-26 09:17:40",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)2020年度权益分派10派2元 股权登记日为5月27日",
    "href": "http://stock.jrj.com.cn/2021/05/21194732794841.shtml",
    "datetime": "2021-05-21 19:47:58",
    "code": "002317"
  },
  {
    "title": "众生药业：创新药物ZSP1273项目正在开展治疗成人单纯性甲型流感的III期临床试验",
    "href": "http://stock.jrj.com.cn/2021/05/14091732752968.shtml",
    "datetime": "2021-05-14 09:17:11",
    "code": "002317"
  },
  {
    "title": "众生药业：爱尔眼科将公司眼科产品列入其旗下医院的基本用药目录",
    "href": "http://stock.jrj.com.cn/2021/05/13172332749103.shtml",
    "datetime": "2021-05-13 17:23:15",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)截至4月底已累计回购63.06万股",
    "href": "http://stock.jrj.com.cn/2021/05/07191132712713.shtml",
    "datetime": "2021-05-07 19:11:13",
    "code": "002317"
  },
  {
    "title": "众生药业：众生睿创抗病毒项目正在药物发现阶段",
    "href": "http://stock.jrj.com.cn/2021/04/29205732482320.shtml",
    "datetime": "2021-04-29 20:57:41",
    "code": "002317"
  },
  {
    "title": "众生药业：交易性金融资产为公司持有的爱尔眼科股票",
    "href": "http://stock.jrj.com.cn/2021/04/29205632482315.shtml",
    "datetime": "2021-04-29 20:56:14",
    "code": "002317"
  },
  {
    "title": "众生药业：公司本次回购股份资金充足",
    "href": "http://stock.jrj.com.cn/2021/04/14085132369108.shtml",
    "datetime": "2021-04-14 08:51:58",
    "code": "002317"
  },
  {
    "title": "众生药业：公司积极采取多种措施降低疫情的影响如跟进国家流感监测中心数据和中心流感患者就诊情况",
    "href": "http://stock.jrj.com.cn/2021/04/09171432343034.shtml",
    "datetime": "2021-04-09 17:14:29",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：控股子公司获得欧洲专利证书",
    "href": "http://stock.jrj.com.cn/2021/03/29174032242144.shtml",
    "datetime": "2021-03-29 17:40:10",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：3月26日首次回购306.04万元股份",
    "href": "http://stock.jrj.com.cn/2021/03/26182132223714.shtml",
    "datetime": "2021-03-26 18:21:41",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：子公司获得一项日本专利证书",
    "href": "http://stock.jrj.com.cn/2021/03/24175832209647.shtml",
    "datetime": "2021-03-24 17:58:54",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：ZSP1273颗粒剂获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/03/11195032110732.shtml",
    "datetime": "2021-03-11 19:50:18",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：截至2月底 尚未开始回购股份",
    "href": "http://stock.jrj.com.cn/2021/03/01174432051258.shtml",
    "datetime": "2021-03-01 17:44:24",
    "code": "002317"
  },
  {
    "title": "众生药业：截至目前 公司已有6个一类创新药项目及2个改良型新药项目完成临床前研究工作",
    "href": "http://stock.jrj.com.cn/2021/02/10133131882901.shtml",
    "datetime": "2021-02-10 13:31:05",
    "code": "002317"
  },
  {
    "title": "A股异动 | 众生药业(002317.SZ)涨近5% 拟以0.5亿元-1亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2021/02/08102631868605.shtml",
    "datetime": "2021-02-08 10:26:07",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)拟以0.5亿元-1亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2021/02/07211231862093.shtml",
    "datetime": "2021-02-07 21:12:43",
    "code": "002317"
  },
  {
    "title": "众生药业将花不超1亿元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2021/02/07200131861919.shtml",
    "datetime": "2021-02-07 20:01:20",
    "code": "002317"
  },
  {
    "title": "众生药业：ZSP1273颗粒剂将按流感相关指导原则和目标人群 合理的推进",
    "href": "http://stock.jrj.com.cn/2021/01/27181331791654.shtml",
    "datetime": "2021-01-27 18:13:35",
    "code": "002317"
  },
  {
    "title": "众生药业：众生睿创在研的广谱抗病毒项目（包括抗新冠病毒）正在药物发现阶段",
    "href": "http://stock.jrj.com.cn/2021/01/25184331767583.shtml",
    "datetime": "2021-01-25 18:43:36",
    "code": "002317"
  },
  {
    "title": "众生药业：商誉减值对创新药研发没有影响",
    "href": "http://stock.jrj.com.cn/2021/01/25175931767188.shtml",
    "datetime": "2021-01-25 17:59:47",
    "code": "002317"
  },
  {
    "title": "众生药业：全资子公司暂未开展NMN生产工作 该产品不属于全资子公司主要产品",
    "href": "http://stock.jrj.com.cn/2021/01/19142031721705.shtml",
    "datetime": "2021-01-19 14:20:37",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：控股子公司获得一项韩国专利证书",
    "href": "http://stock.jrj.com.cn/2021/01/15185431700690.shtml",
    "datetime": "2021-01-15 18:54:59",
    "code": "002317"
  },
  {
    "title": "众生药业：处于临床前阶段的一类创新中药QU100脂质体冻干粉针剂项目已经综合评估后终止",
    "href": "http://stock.jrj.com.cn/2021/01/13173631685056.shtml",
    "datetime": "2021-01-13 17:36:53",
    "code": "002317"
  },
  {
    "title": "高溢价并购推高商誉 众生药业大幅计提后隐患仍存",
    "href": "http://stock.jrj.com.cn/2021/01/11072531667417.shtml",
    "datetime": "2021-01-11 07:25:30",
    "code": "002317"
  },
  {
    "title": "众生药业：公司关注当前业务基础 强化核心产品护城河能力",
    "href": "http://stock.jrj.com.cn/2021/01/08163831655608.shtml",
    "datetime": "2021-01-08 16:38:23",
    "code": "002317"
  },
  {
    "title": "众生药业：强药业特色原料药市场在国内国外都有 目前以国内为主",
    "href": "http://stock.jrj.com.cn/2021/01/08163631655594.shtml",
    "datetime": "2021-01-08 16:36:42",
    "code": "002317"
  },
  {
    "title": "众生药业：公司全资子公司开发的NMN（β-烟酰胺单核苷酸）无需进行公示",
    "href": "http://stock.jrj.com.cn/2021/01/08163031655556.shtml",
    "datetime": "2021-01-08 16:30:19",
    "code": "002317"
  },
  {
    "title": "众生药业控股股东张玉冲质押300万股 用于补充质押",
    "href": "http://stock.jrj.com.cn/2021/01/06211531643632.shtml",
    "datetime": "2021-01-06 21:15:31",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：实控人张玉冲质押300万股",
    "href": "http://stock.jrj.com.cn/2021/01/06195631643314.shtml",
    "datetime": "2021-01-06 19:56:07",
    "code": "002317"
  },
  {
    "title": "众生药业近9亿商誉减值或致上市首亏 “罪魁祸首”已存续分立有财务操纵之嫌",
    "href": "http://stock.jrj.com.cn/2021/01/06114431640500.shtml",
    "datetime": "2021-01-06 11:44:25",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)及控股子公司分别取得发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/01/05202231636366.shtml",
    "datetime": "2021-01-05 20:22:27",
    "code": "002317"
  },
  {
    "title": "众生药业：先强药业是珠三角地区为数不多的具备原料药研发、生产能力的制药企业之一",
    "href": "http://stock.jrj.com.cn/2021/01/05183231635595.shtml",
    "datetime": "2021-01-05 18:32:26",
    "code": "002317"
  },
  {
    "title": "众生药业17亿收购两公司业绩变脸 计提8.9亿商誉减值致上市首亏逾4亿",
    "href": "http://stock.jrj.com.cn/2021/01/05081731631764.shtml",
    "datetime": "2021-01-05 08:17:18",
    "code": "002317"
  },
  {
    "title": "众生药业产品困境：多个单品2020年销售、研发遇阻 创新药项目却还“在路上”",
    "href": "http://stock.jrj.com.cn/2021/01/04201231629026.shtml",
    "datetime": "2021-01-04 20:12:40",
    "code": "002317"
  },
  {
    "title": "众生药业2020年预计亏损3.8亿-4.5亿 上半年受疫情影响销售急剧下降",
    "href": "http://stock.jrj.com.cn/2021/01/04195431628928.shtml",
    "datetime": "2021-01-04 19:54:19",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业1月4日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/01/04180131628044.shtml",
    "datetime": "2021-01-04 18:01:23",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)2020年度预亏3.8亿元-4.5亿元",
    "href": "http://stock.jrj.com.cn/2021/01/04162631627380.shtml",
    "datetime": "2021-01-04 16:26:55",
    "code": "002317"
  },
  {
    "title": "众生药业：2020年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2021/01/03225031622709.shtml",
    "datetime": "2021-01-03 22:50:00",
    "code": "002317"
  },
  {
    "title": "众生药业：预计2020年亏损3.8亿元-4.5亿元 由盈转亏",
    "href": "http://stock.jrj.com.cn/2021/01/03171231622039.shtml",
    "datetime": "2021-01-03 17:12:56",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：一类创新药ZSP1273颗粒剂临床试验注册申请获得受理",
    "href": "http://stock.jrj.com.cn/2020/12/28213831588607.shtml",
    "datetime": "2020-12-28 21:38:36",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：众生睿创拟以现金增资方式引入投资者",
    "href": "http://stock.jrj.com.cn/2020/12/15202131496422.shtml",
    "datetime": "2020-12-15 20:21:24",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：设立北京分公司",
    "href": "http://stock.jrj.com.cn/2020/12/15201231496402.shtml",
    "datetime": "2020-12-15 20:12:16",
    "code": "002317"
  },
  {
    "title": "[众生药业]新一代流感病毒聚合酶抑制剂ZSP1273片启动Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2020/12/07000031428901.shtml",
    "datetime": "2020-12-07 00:00:00",
    "code": "002317"
  },
  {
    "title": "众生药业：公司积极和潜在战略投资者沟通 会在合适时机开放平台",
    "href": "http://stock.jrj.com.cn/2020/11/19114131314786.shtml",
    "datetime": "2020-11-19 11:41:42",
    "code": "002317"
  },
  {
    "title": "众生药业：公司布局治疗非酒精性脂肪肝炎一类创新药时间较早",
    "href": "http://stock.jrj.com.cn/2020/11/10181431252401.shtml",
    "datetime": "2020-11-10 18:14:59",
    "code": "002317"
  },
  {
    "title": "众生药业2020年前三季度净利3.01亿下滑18.21% 产品销售受疫情影响减少",
    "href": "http://stock.jrj.com.cn/2020/10/28091931148740.shtml",
    "datetime": "2020-10-28 09:19:29",
    "code": "002317"
  },
  {
    "title": "众生药业：ZSP1603项目已完成I期临床试验并获得临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2020/10/22170331109406.shtml",
    "datetime": "2020-10-22 17:03:30",
    "code": "002317"
  },
  {
    "title": "众生药业：公司及子公司拥有地塞米松片剂及乳膏剂的生产批文",
    "href": "http://stock.jrj.com.cn/2020/10/20184331093599.shtml",
    "datetime": "2020-10-20 18:43:21",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：控股股东方面质押2041万股及解押2400万股",
    "href": "http://stock.jrj.com.cn/2020/10/16130431067188.shtml",
    "datetime": "2020-10-16 13:04:10",
    "code": "002317"
  },
  {
    "title": "[众生药业]快讯!公司获颁发“新冠肺炎疫情防控物资保障工作重要贡献企业”牌匾",
    "href": "http://stock.jrj.com.cn/2020/10/10000031029064.shtml",
    "datetime": "2020-10-10 00:00:00",
    "code": "002317"
  },
  {
    "title": "众生药业(002317.SZ)：控股子公司完成工商变更登记",
    "href": "http://stock.jrj.com.cn/2020/10/08181330992836.shtml",
    "datetime": "2020-10-08 18:13:47",
    "code": "002317"
  },
  {
    "title": "众生药业：ZSP1273项目处于III期临床准备阶段",
    "href": "http://stock.jrj.com.cn/2020/09/14221230750100.shtml",
    "datetime": "2020-09-14 22:12:49",
    "code": "002317"
  },
  {
    "title": "电鳗财经|继续下陷！众生药业扣非净利润大降六成 今年业绩增长可能有点儿“悬”了",
    "href": "http://stock.jrj.com.cn/invest/2020/08/26084630591608.shtml",
    "datetime": "2020-08-26 08:46:00",
    "code": "002317"
  },
  {
    "title": "继续下陷！众生药业扣非净利润大降六成 今年业绩增长可能有点儿“悬”了",
    "href": "http://stock.jrj.com.cn/2020/08/26084130591602.shtml",
    "datetime": "2020-08-26 08:41:00",
    "code": "002317"
  },
  {
    "title": "众生药业2020年上半年净利1.92亿减少37% 诊所处于停业状态",
    "href": "http://stock.jrj.com.cn/2020/08/25192030587393.shtml",
    "datetime": "2020-08-25 19:20:26",
    "code": "002317"
  },
  {
    "title": "众生药业：子公司开发的NMN处于中试阶段 尚未销售",
    "href": "http://stock.jrj.com.cn/2020/08/14154130499385.shtml",
    "datetime": "2020-08-14 15:41:52",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业7月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/22180130316055.shtml",
    "datetime": "2020-07-22 18:01:14",
    "code": "002317"
  },
  {
    "title": "众生药业：控股子公司众生睿创未来将选择合适的市场板块独立上市",
    "href": "http://stock.jrj.com.cn/2020/07/16113930259443.shtml",
    "datetime": "2020-07-16 11:39:33",
    "code": "002317"
  },
  {
    "title": "众生药业：ZSP1603项目已完成I期临床试验并获得临床试验总结报告",
    "href": "http://stock.jrj.com.cn/2020/07/10133930204171.shtml",
    "datetime": "2020-07-10 13:39:18",
    "code": "002317"
  },
  {
    "title": "众生药业：一类创新药ZSP1603项目已完成I期临床试验并达到预期目标",
    "href": "http://stock.jrj.com.cn/2020/07/10112830204765.shtml",
    "datetime": "2020-07-10 11:28:18",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业7月1日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/01180030112590.shtml",
    "datetime": "2020-07-01 18:00:24",
    "code": "002317"
  },
  {
    "title": "快讯：众生药业急速拉升8.22% 主力资金净流出5772.49万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/01111830109118.shtml",
    "datetime": "2020-07-01 11:18:00",
    "code": "002317"
  },
  {
    "title": "龙虎榜：众生药业涨停 四机构买入1.71亿元",
    "href": "http://stock.jrj.com.cn/2020/06/30170830098374.shtml",
    "datetime": "2020-06-30 17:08:49",
    "code": "002317"
  },
  {
    "title": "快讯：众生药业急速拉升7.44% 主力资金净流出30.03万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/30094630094290.shtml",
    "datetime": "2020-06-30 09:46:22",
    "code": "002317"
  },
  {
    "title": "快讯：众生药业急速拉升7.44% 主力资金净流入190.72万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/30094530094279.shtml",
    "datetime": "2020-06-30 09:45:23",
    "code": "002317"
  },
  {
    "title": "【龙虎榜】众生药业6月29日成交明细(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/29173830087871.shtml",
    "datetime": "2020-06-29 17:38:54",
    "code": "002317"
  },
  {
    "title": "快讯：众生药业急速拉升7.27% 主力资金净流入2105.89万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/23094829996170.shtml",
    "datetime": "2020-06-23 09:48:11",
    "code": "002317"
  },
  {
    "title": "[众生药业]广东省药品监督管理局局长江效东莅临公司走访调研",
    "href": "http://stock.jrj.com.cn/2020/05/13000029675365.shtml",
    "datetime": "2020-05-13 00:00:00",
    "code": "002317"
  },
  {
    "title": "众生药业第一季度盈利5272.59万同比下滑58.15% 研发费用同比增加",
    "href": "http://stock.jrj.com.cn/2020/05/01184429440822.shtml",
    "datetime": "2020-05-01 18:44:58",
    "code": "002317"
  },
  {
    "title": "众生药业第一季度盈利5272.58万同比减少58.15% 研发费用增加",
    "href": "http://stock.jrj.com.cn/2020/04/29132429417855.shtml",
    "datetime": "2020-04-29 13:24:12",
    "code": "002317"
  },
  {
    "title": "众生药业2019年净利同比下降27%",
    "href": "http://stock.jrj.com.cn/2020/04/28224329408522.shtml",
    "datetime": "2020-04-28 22:43:05",
    "code": "002317"
  },
  {
    "title": "众生药业2019年净利3.18亿减少27.07% 公司主动进行研发策略调整",
    "href": "http://stock.jrj.com.cn/2020/04/28220329408244.shtml",
    "datetime": "2020-04-28 22:03:37",
    "code": "002317"
  },
  {
    "title": "众生药业全资子公司格列齐特片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/04/23215829360941.shtml",
    "datetime": "2020-04-23 21:58:55",
    "code": "002317"
  },
  {
    "title": "众生药业：子公司格列齐特片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/04/23203729360484.shtml",
    "datetime": "2020-04-23 20:37:00",
    "code": "002317"
  },
  {
    "title": "众生药业：子公司格列齐特片通过仿制药一致性评价 目前为国内唯一",
    "href": "http://stock.jrj.com.cn/2020/04/23203329360426.shtml",
    "datetime": "2020-04-23 20:33:44",
    "code": "002317"
  },
  {
    "title": "众生药业2020年第一季度亏损5039.84万元–7559.75万元 同比下降40%-60%",
    "href": "http://stock.jrj.com.cn/2020/04/15114229294576.shtml",
    "datetime": "2020-04-15 11:42:47",
    "code": "002317"
  },
  {
    "title": "众生药业：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/15080029292351.shtml",
    "datetime": "2020-04-15 08:00:36",
    "code": "002317"
  },
  {
    "title": "[众生药业]东莞市委书记、市人大常委主任梁维东莅临公司调研复工复产情况",
    "href": "http://stock.jrj.com.cn/2020/04/02000029181025.shtml",
    "datetime": "2020-04-02 00:00:00",
    "code": "002317"
  },
  {
    "title": "[众生药业]关于公司参与新冠肺炎疫情应急演练的通告",
    "href": "http://stock.jrj.com.cn/2020/03/07000028976182.shtml",
    "datetime": "2020-03-07 00:00:00",
    "code": "002317"
  },
  {
    "title": "众生药业2019年净利同比下降26.78%",
    "href": "http://stock.jrj.com.cn/2020/02/26195228899268.shtml",
    "datetime": "2020-02-26 19:52:31",
    "code": "002317"
  },
  {
    "title": "众生药业：公司磷酸氯喹片已在正常生产",
    "href": "http://stock.jrj.com.cn/2020/02/19130328854635.shtml",
    "datetime": "2020-02-19 13:03:00",
    "code": "002317"
  },
  {
    "title": "[众生药业]市人大常委会副主任、市总工会主席陈锡江莅临公司走访慰问",
    "href": "http://stock.jrj.com.cn/2020/02/19000028859670.shtml",
    "datetime": "2020-02-19 00:00:00",
    "code": "002317"
  },
  {
    "title": "众生药业参与治疗新冠肺炎临床研究",
    "href": "http://stock.jrj.com.cn/2020/02/14220428831681.shtml",
    "datetime": "2020-02-14 22:04:44",
    "code": "002317"
  },
  {
    "title": "众生药业：参与磷酸氯喹片治疗新型冠状病毒肺炎临床研究",
    "href": "http://stock.jrj.com.cn/2020/02/14200728831282.shtml",
    "datetime": "2020-02-14 20:07:34",
    "code": "002317"
  },
  {
    "title": "众生药业将参与磷酸氯喹片治疗新型冠状病毒肺炎的临床研究",
    "href": "http://stock.jrj.com.cn/2020/02/14195528831248.shtml",
    "datetime": "2020-02-14 19:55:04",
    "code": "002317"
  },
  {
    "title": "众生药业：参与磷酸氯喹片治疗新型冠状病毒肺炎的临床研究",
    "href": "http://stock.jrj.com.cn/2020/02/14195228831236.shtml",
    "datetime": "2020-02-14 19:52:00",
    "code": "002317"
  },
  {
    "title": "众生药业：将参与磷酸氯喹片治疗新型冠状病毒肺炎的临床研究",
    "href": "http://stock.jrj.com.cn/2020/02/14193528831164.shtml",
    "datetime": "2020-02-14 19:35:08",
    "code": "002317"
  },
  {
    "title": "众生药业：已于2月10日有序开工 目前采取以现场和远程办公相结合的方式开展工作",
    "href": "http://stock.jrj.com.cn/2020/02/11222328811633.shtml",
    "datetime": "2020-02-11 22:23:00",
    "code": "002317"
  },
  {
    "title": "[众生药业]抗击疫情--众生药业磷酸氯喹片恢复生产 支持医疗机构开展临床研究",
    "href": "http://stock.jrj.com.cn/2020/02/11000028807723.shtml",
    "datetime": "2020-02-11 00:00:00",
    "code": "002317"
  },
  {
    "title": "[众生药业]抗击疫情--众生药业磷酸氯喹片恢复生产 支持医疗机构开展临床研究",
    "href": "http://stock.jrj.com.cn/2020/02/11000030648135.shtml",
    "datetime": "2020-02-11 00:00:00",
    "code": "002317"
  },
  {
    "title": "众生药业：公司完成磷酸氯喹片恢复生产的相关工作",
    "href": "http://stock.jrj.com.cn/2020/02/10204528804768.shtml",
    "datetime": "2020-02-10 20:45:05",
    "code": "002317"
  },
  {
    "title": "众生药业完成磷酸氯喹片恢复生产的相关工作",
    "href": "http://stock.jrj.com.cn/2020/02/10193728804527.shtml",
    "datetime": "2020-02-10 19:37:46",
    "code": "002317"
  },
  {
    "title": "众生药业：完成磷酸氯喹片恢复生产的相关工作",
    "href": "http://stock.jrj.com.cn/2020/02/10191428804431.shtml",
    "datetime": "2020-02-10 19:14:00",
    "code": "002317"
  },
  {
    "title": "众生药业：公司药品磷酸氯喹片恢复生产 氯喹对新型冠状病毒具有一定体外抑制活性",
    "href": "http://stock.jrj.com.cn/2020/02/10191328804416.shtml",
    "datetime": "2020-02-10 19:13:16",
    "code": "002317"
  },
  {
    "title": "[众生药业]拼下去 活下来——集团公司2019年度干部会议暨先进表彰大会",
    "href": "http://stock.jrj.com.cn/2020/01/20000028707117.shtml",
    "datetime": "2020-01-20 00:00:00",
    "code": "002317"
  },
  {
    "title": "众生药业子公司应收账款逾期 将影响年度利润逾5000万元",
    "href": "http://stock.jrj.com.cn/2020/01/15052128678028.shtml",
    "datetime": "2020-01-15 05:21:58",
    "code": "002317"
  },
  {
    "title": "众生药业：氢溴酸右美沙芬片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/01/08202328645379.shtml",
    "datetime": "2020-01-08 20:23:39",
    "code": "002317"
  },
  {
    "title": "众生药业：子公司氢溴酸右美沙芬片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/01/08193228645210.shtml",
    "datetime": "2020-01-08 19:32:00",
    "code": "002317"
  },
  {
    "title": "[众生药业]我们都是追梦人 我们一直在路上",
    "href": "http://stock.jrj.com.cn/2019/12/31000028610159.shtml",
    "datetime": "2019-12-31 00:00:00",
    "code": "002317"
  },
  {
    "title": "[众生药业]龙超峰同志荣获“庆祝中华人民共和国成立70周年”纪念章",
    "href": "http://stock.jrj.com.cn/2019/12/31000028625447.shtml",
    "datetime": "2019-12-31 00:00:00",
    "code": "002317"
  },
  {
    "title": "众生药业：子公司头孢拉定胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/12/30185328605124.shtml",
    "datetime": "2019-12-30 18:53:43",
    "code": "002317"
  },
  {
    "title": "众生药业子公司头孢拉定胶囊获药监局批文",
    "href": "http://stock.jrj.com.cn/2019/12/30185228605126.shtml",
    "datetime": "2019-12-30 18:52:36",
    "code": "002317"
  },
  {
    "title": "众生药业：头孢拉定胶囊通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/12/30182828604753.shtml",
    "datetime": "2019-12-30 18:28:00",
    "code": "002317"
  },
  {
    "title": "众生药业：一类创新药ZSP0678片新增适应症临床试验注册申请获受理",
    "href": "http://stock.jrj.com.cn/2019/12/26221928592883.shtml",
    "datetime": "2019-12-26 22:19:46",
    "code": "002317"
  },
  {
    "title": "[众生药业]广东省副省长陈良贤莅临公司视察调研",
    "href": "http://stock.jrj.com.cn/2019/12/26000028589219.shtml",
    "datetime": "2019-12-26 00:00:00",
    "code": "002317"
  },
  {
    "title": "[众生药业]公司退休员工2020年迎春茶话会",
    "href": "http://stock.jrj.com.cn/2019/12/17000028625449.shtml",
    "datetime": "2019-12-17 00:00:00",
    "code": "002317"
  },
  {
    "title": "[众生药业]40载春华秋实 追梦人一直在路上——热烈庆祝众生药业成立40周年暨上市10周年",
    "href": "http://stock.jrj.com.cn/2019/12/13000028545129.shtml",
    "datetime": "2019-12-13 00:00:00",
    "code": "002317"
  },
  {
    "title": "众生药业：甲型流感及人禽流感的ZSP1273片临床研究取得实质性进展",
    "href": "http://stock.jrj.com.cn/2019/12/09071928505551.shtml",
    "datetime": "2019-12-09 07:19:50",
    "code": "002317"
  },
  {
    "title": "众生药业：预防和治疗甲型流感及人禽流感的ZSP1273片临床研究取得实质性进展",
    "href": "http://stock.jrj.com.cn/2019/12/08220428504506.shtml",
    "datetime": "2019-12-08 22:04:38",
    "code": "002317"
  },
  {
    "title": "众生药业预防和治疗甲型流感及人禽流感的一类创新药取得实质性进展",
    "href": "http://stock.jrj.com.cn/2019/12/08174728504161.shtml",
    "datetime": "2019-12-08 17:47:36",
    "code": "002317"
  },
  {
    "title": "众生药业：预防和治疗甲型流感及人禽流感的ZSP1273片临床研究取得实质性进展",
    "href": "http://stock.jrj.com.cn/2019/12/08165628504096.shtml",
    "datetime": "2019-12-08 16:56:00",
    "code": "002317"
  },
  {
    "title": "众生药业拟投3000万元设控股子公司",
    "href": "http://stock.jrj.com.cn/2019/12/04083128486721.shtml",
    "datetime": "2019-12-04 08:31:27",
    "code": "002317"
  },
  {
    "title": "[用友网络]众生药业启动用友NC Cloud项目,打造集团财务数字化平台",
    "href": "http://stock.jrj.com.cn/2019/12/03000028488412.shtml",
    "datetime": "2019-12-03 00:00:00",
    "code": "002317"
  },
  {
    "title": "[众生药业]关于开展危险化学品生产安全事故应急演练的通告",
    "href": "http://stock.jrj.com.cn/2019/11/15000028409922.shtml",
    "datetime": "2019-11-15 00:00:00",
    "code": "002317"
  },
  {
    "title": "众生药业控股子公司收到美国专利商标局颁发的专利证书",
    "href": "http://stock.jrj.com.cn/2019/11/12104628386887.shtml",
    "datetime": "2019-11-12 10:46:19",
    "code": "002317"
  },
  {
    "title": "众生药业：控股子公司获得美国专利证书",
    "href": "http://stock.jrj.com.cn/2019/11/11223528382145.shtml",
    "datetime": "2019-11-11 22:35:18",
    "code": "002317"
  },
  {
    "title": "[众生药业]众生药业上榜“中国医药·品牌榜”医院终端榜单",
    "href": "http://stock.jrj.com.cn/2019/11/06000028358389.shtml",
    "datetime": "2019-11-06 00:00:00",
    "code": "002317"
  },
  {
    "title": "众生药业：获得发明专利证书",
    "href": "http://stock.jrj.com.cn/2019/10/31220228335396.shtml",
    "datetime": "2019-10-31 22:02:34",
    "code": "002317"
  },
  {
    "title": "众生药业一共聚物制备法获发明专利",
    "href": "http://stock.jrj.com.cn/2019/10/31213128335269.shtml",
    "datetime": "2019-10-31 21:31:35",
    "code": "002317"
  },
  {
    "title": "[众生药业]众生药业与爱尔眼科签署战略合作框架协议",
    "href": "http://stock.jrj.com.cn/2019/10/25000028298850.shtml",
    "datetime": "2019-10-25 00:00:00",
    "code": "002317"
  },
  {
    "title": "众生药业与爱尔眼科达成战略合作 优势互补业务联动发展",
    "href": "http://stock.jrj.com.cn/invest/2019/10/23073228286149.shtml",
    "datetime": "2019-10-23 07:32:00",
    "code": "002317"
  }
]